Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,250,721 papers from all fields of science
Search
Sign In
Create Free Account
J 104132
Known as:
J-104132
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Endothelin receptor antagonist
Pyridines
L 753037
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Endothelin ETB Receptor Is Involved in Sex Differences in the Development of Balloon Injury-Induced Neointimal Formation
Kento Kitada
,
Nozomi Yui
,
+6 authors
Y. Matsumura
Journal of Pharmacology and Experimental…
2011
Corpus ID: 12418072
The purpose of this study was to evaluate the involvement of endothelin (ET)B receptor-mediated action in the sex differences in…
Expand
2009
2009
Inhibition of Endothelin ETB Receptor System Aggravates Neointimal Hyperplasia after Balloon Injury of Rat Carotid Artery
Kento Kitada
,
Nozomi Yui
,
Chika Matsumoto
,
Tatsuhiko Mori
,
M. Ohkita
,
Y. Matsumura
Journal of Pharmacology and Experimental…
2009
Corpus ID: 319372
Endothelin-1 (ET)/ETA receptor system has been known to play an important role in the pathogenesis of neointimal hyperplasia…
Expand
2004
2004
Hepatobiliary Transport of a Nonpeptidic Endothelin Antagonist, (+)-(5S,6R, 7R)-2-Butyl-7-[2((2S)-2-Carboxypropyl)-4-Methoxyphenyl]-5-(3,4-Methylenedioxyphenyl) Cyclopentenol[1,2-b]Pyridine-6…
N. Kobayashi
,
T. Tani
,
A. Hisaka
,
K. Hara
,
T. Yasumori
Pharmaceutical Research
2004
Corpus ID: 24225408
AbstractPurpose. Hepatobiliary excretions of drugs from the blood to the bile include two essential transmembrane processes…
Expand
Highly Cited
2002
Highly Cited
2002
Effects of chronic administration of the novel endothelin antagonist J‐104132 on endothelial dysfunction in streptozotocin‐induced diabetic rat
N. Kanie
,
K. Kamata
British Journal of Pharmacology
2002
Corpus ID: 35651918
The biosynthesis of endothelin‐1 is increased in the diabetic state. So this peptide may cause diabetic vascular complications…
Expand
2002
2002
ects of chronic administration of the novel endothelin antagonist J-104132 on endothelial dysfunction in streptozotocin-induced diabetic rat
N. Kanie
,
K. Kamata
2002
Corpus ID: 30504082
1 The biosynthesis of endothelin-1 is increased in the diabetic state. So this peptide may cause diabetic vascular complications…
Expand
2001
2001
Pathophysiological roles of endogenous endothelin-1 in dogs with chronic heart failure produced by rapid right ventricular pacing.
K. Tadano
,
J. Suzuki
,
+6 authors
M. Nishikibe
Journal of Pharmacology and Experimental…
2001
Corpus ID: 24964086
This study was designed to analyze the pathophysiological role of the endogenous endothelin (ET) system and the therapeutic…
Expand
2000
2000
Antihypertensive effects of a mixed endothelin-A- and -B-receptor antagonist, J-104132, were augmented in the presence of an AT1 -receptor antagonist, MK-954.
T. Ikeda
,
H. Ohta
,
+6 authors
M. Nishikibe
Journal of Cardiovascular Pharmacology
2000
Corpus ID: 9418973
The single oral administration of a mixed endothelin-A-and -B- (ETA/ETB) receptor antagonist, J-104132 (L-753,037) decreased the…
Expand
1999
1999
Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist.
M. Nishikibe
,
H. Ohta
,
+20 authors
P. Siegl
Journal of Pharmacology and Experimental…
1999
Corpus ID: 21012341
J-104132 [(+)-(5S,6R, 7R)-2-butyl-7-[2-((2S)-2-carboxypropyl)-4-methoxyphenyl]-5-(3, 4-methylenedioxyphenyl)cyclopenteno[1,2-b…
Expand
1999
1999
Pathophysiological roles of endothelin-1 in Dahl salt-sensitive hypertension.
T. Ikeda
,
H. Ohta
,
+7 authors
M. Nishikibe
HYPERTENSION
1999
Corpus ID: 15120436
The purpose of the present experiment was to study the pathophysiological roles of endothelin-1 (ET-1) in salt-sensitive…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE